M Holdings Securities’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.65M | Sell |
101,348
-35,456
| -26% | -$944K | 0.18% | 105 |
|
|
2025
Q4 | $3.41M | Buy |
136,804
+119,508
| +691% | +$3.01M | 0.24% | 77 |
|
|
2025
Q3 | $441K | Buy |
+17,296
| New | +$427K | 0.09% | 79 |
|
|
2025
Q2 | – | Sell |
-79,018
| Closed | -$2M | – | 197 |
|
|
2025
Q1 | $2M | Sell |
79,018
-1,798
| -2% | -$47K | 0.33% | 62 |
|
|
2024
Q4 | $2.14M | Buy |
+80,816
| New | +$2.19M | 0.35% | 58 |
|
|
2024
Q2 | – | Sell |
-40,440
| Closed | -$1.12M | – | 338 |
|
|
2024
Q1 | $1.12M | Sell |
40,440
-13,411
| -25% | -$372K | 0.19% | 75 |
|
|
2023
Q4 | $1.55M | Sell |
53,851
-9,935
| -16% | -$300K | 0.18% | 89 |
|
|
2023
Q3 | $2.12M | Buy |
63,786
+51,960
| +439% | +$1.84M | 0.28% | 67 |
|
|
2023
Q2 | $434K | Buy |
+11,826
| New | +$460K | 0.09% | 119 |
|
|
2023
Q1 | – | Sell |
-65,897
| Closed | -$2.85M | – | 555 |
|
|
2022
Q4 | $3.38M | Buy |
65,897
+1,081
| +2% | +$51.8K | 0.36% | 57 |
|
|
2022
Q3 | $2.84M | Sell |
64,816
-425
| -0.7% | -$20.7K | 0.31% | 71 |
|
|
2022
Q2 | $3.42M | Sell |
65,241
-1,290
| -2% | -$65.7K | 0.35% | 65 |
|
|
2022
Q1 | $3.44M | Buy |
+66,531
| New | +$3.45M | 0.26% | 76 |
|
|
2021
Q2 | $2.65M | Sell |
67,620
-26
| -0% | -$1.01K | 0.26% | 87 |
|
|
2021
Q1 | $2.45M | Buy |
67,646
+9,485
| +16% | +$337K | 0.22% | 97 |
|
|
2020
Q4 | $2.14M | Sell |
58,161
-2,131
| -4% | -$78.2K | 0.27% | 77 |
|
|
2020
Q3 | $2.1M | Buy |
60,292
+2,417
| +4% | +$84.7K | 0.33% | 72 |
|
|
2020
Q2 | $1.8M | Sell |
57,875
-26,436
| -31% | -$898K | 0.32% | 79 |
|
|
2020
Q1 | $2.61M | Buy |
84,311
+29,054
| +53% | +$990K | 0.39% | 76 |
|
|
2019
Q4 | $2.05M | Sell |
55,257
-3,161
| -5% | -$113K | 0.6% | 54 |
|
|
2019
Q3 | $1.99M | Buy |
58,418
+3,187
| +6% | +$116K | 0.61% | 51 |
|
|
2019
Q2 | $2.27M | Buy |
55,231
+13,228
| +31% | +$525K | 0.77% | 37 |
|
|
2019
Q1 | $1.69M | Buy |
42,003
+9,162
| +28% | +$367K | 0.39% | 68 |
|
|
2018
Q4 | $1.36M | Buy |
32,841
+1,861
| +6% | +$77.3K | 0.42% | 59 |
|
|
2018
Q3 | $1.29M | Buy |
30,980
+946
| +3% | +$36.4K | 0.34% | 74 |
|
|
2018
Q2 | $1.03M | Buy |
30,034
+3,195
| +12% | +$109K | 0.28% | 99 |
|
|
2018
Q1 | $904K | Sell |
26,839
-700
| -3% | -$24.1K | 0.28% | 112 |
|
|
2017
Q4 | $946K | Sell |
27,539
-236
| -0.8% | -$8.05K | 0.29% | 106 |
|
|
2017
Q3 | $941K | Buy |
27,775
+333
| +1% | +$10.7K | 0.3% | 94 |
|
|
2017
Q2 | $875K | Buy |
27,442
+8,047
| +41% | +$254K | 0.3% | 96 |
|
|
2017
Q1 | $629K | Buy |
19,395
+2,523
| +15% | +$79.5K | 0.24% | 116 |
|
|
2016
Q4 | $520K | Sell |
16,872
-4,013
| -19% | -$123K | 0.18% | 128 |
|
|
2016
Q3 | $671K | Sell |
20,885
-249
| -1% | -$8.33K | 0.31% | 95 |
|
|
2016
Q2 | $706K | Buy |
21,134
+6,608
| +45% | +$211K | 0.36% | 78 |
|
|
2016
Q1 | $408K | Buy |
14,526
+1,704
| +13% | +$48.7K | 0.25% | 120 |
|
|
2015
Q4 | $393K | Sell |
12,822
-1,874
| -13% | -$59K | 0.26% | 112 |
|
|
2015
Q3 | $438K | Sell |
14,696
-2,617
| -15% | -$83.9K | 0.31% | 98 |
|
|
2015
Q2 | $551K | Buy |
17,313
+707
| +4% | +$23K | 0.37% | 80 |
|
|
2015
Q1 | $548K | Sell |
16,606
-2,007
| -11% | -$63.8K | 0.36% | 84 |
|
|
2014
Q4 | $550K | Buy |
18,613
+1,531
| +9% | +$43.9K | 0.36% | 85 |
|
|
2014
Q3 | $496K | Sell |
17,082
-4,230
| -20% | -$119K | 0.28% | 87 |
|
|
2014
Q2 | $600K | Buy |
21,312
+8,949
| +72% | +$255K | 0.38% | 74 |
|
|
2014
Q1 | $377K | Sell |
12,363
-2,189
| -15% | -$65.3K | 0.4% | 69 |
|
|
2013
Q4 | $423K | Buy |
+14,552
| New | +$424K | 0.3% | 88 |
|
Other funds holding PFE
VCM
VPM
M Holdings Securities's PFE Position: Q1 2026 in Review
M Holdings Securities reduced its Pfizer (PFE) stake by 26% in Q1 2026, selling an estimated $944K and leaving 101,348 shares worth $2.65M. The position accounts for 0.18% of the portfolio, ranked #105.
M Holdings Securities first reported a position in PFE in Q4 2013 and has held it in 44 quarters since. The position peaked at $3.44M in Q1 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- M Holdings Securities held 101,348 shares of Pfizer worth $2.65M as of Q1 2026.
- M Holdings Securities sold 35,456 Pfizer shares in Q1 2026, an estimated $944K.
- Pfizer made up 0.18% of M Holdings Securities's portfolio in Q1 2026, its #105 holding.
- M Holdings Securities first reported a position in Pfizer in Q4 2013 and has held it in 44 quarters since.
- M Holdings Securities's Pfizer position peaked at $3.44M in Q1 2022.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on M Holdings Securities's 13F filing for Q1 2026, filed 12 May 2026.